At a Glance
Estimated New Cases in 2024 310,720
% of All New Cancer Cases 15.5%
Estimated Deaths in 2024 42,250
% of All Cancer Deaths 6.9%
5-Year
Relative Survival
91.2% 2014–2020
| Year | Rate of New Cases — SEER 8 | Rate of New Cases — SEER 12 | Death Rate — U.S. | 5-Year Relative Survival — SEER 8 | ||||
|---|---|---|---|---|---|---|---|---|
| Observed | Modeled Trend | Observed | Modeled Trend | Observed | Modeled Trend | Observed | Modeled Trend | |
| 1975 | 106.03 | 103.49 | - | - | 31.45 | 31.48 | 76.20% | 75.59% |
| 1976 | 102.14 | 103.33 | - | - | 31.80 | 31.59 | 75.83% | 75.80% |
| 1977 | 101.66 | 103.17 | - | - | 32.48 | 31.70 | 76.47% | 76.01% |
| 1978 | 101.96 | 103.01 | - | - | 31.73 | 31.82 | 75.40% | 76.21% |
| 1979 | 102.61 | 102.85 | - | - | 31.21 | 31.93 | 75.22% | 76.41% |
| 1980 | 103.25 | 102.69 | - | - | 31.68 | 32.04 | 75.86% | 76.61% |
| 1981 | 105.10 | 102.53 | - | - | 31.92 | 32.16 | 76.30% | 76.81% |
| 1982 | 105.32 | 106.94 | - | - | 32.19 | 32.27 | 77.68% | 77.01% |
| 1983 | 110.03 | 111.54 | - | - | 32.07 | 32.39 | 77.64% | 77.21% |
| 1984 | 115.73 | 116.33 | - | - | 32.90 | 32.50 | 79.17% | 78.89% |
| 1985 | 123.78 | 121.34 | - | - | 32.98 | 32.62 | 79.52% | 80.46% |
| 1986 | 126.92 | 126.55 | - | - | 32.87 | 32.73 | 81.42% | 81.94% |
| 1987 | 134.03 | 132.00 | - | - | 32.66 | 32.85 | 83.96% | 83.31% |
| 1988 | 131.14 | 131.70 | - | - | 33.20 | 32.97 | 85.47% | 84.59% |
| 1989 | 127.19 | 131.40 | - | - | 33.23 | 33.08 | 84.85% | 85.13% |
| 1990 | 131.03 | 131.10 | - | - | 33.14 | 33.20 | 85.52% | 85.65% |
| 1991 | 132.13 | 130.80 | - | - | 32.69 | 32.61 | 86.45% | 86.16% |
| 1992 | 131.30 | 130.50 | 129.17 | 126.21 | 31.64 | 32.04 | 86.65% | 86.66% |
| 1993 | 128.85 | 130.21 | 126.74 | 128.00 | 31.39 | 31.47 | 86.34% | 87.13% |
| 1994 | 131.33 | 129.91 | 128.71 | 129.83 | 30.92 | 30.91 | 87.37% | 87.59% |
| 1995 | 131.99 | 132.46 | 130.23 | 131.67 | 30.55 | 30.37 | 87.33% | 88.04% |
| 1996 | 134.50 | 135.05 | 132.39 | 133.55 | 29.49 | 29.39 | 87.21% | 88.47% |
| 1997 | 137.86 | 137.70 | 135.73 | 135.45 | 28.21 | 28.44 | 89.38% | 88.88% |
| 1998 | 141.57 | 140.39 | 138.79 | 137.38 | 27.54 | 27.52 | 90.26% | 89.29% |
| 1999 | 142.30 | 143.14 | 138.76 | 139.34 | 26.61 | 26.99 | 90.05% | 89.67% |
| 2000 | 136.63 | 139.75 | 134.03 | 136.12 | 26.64 | 26.47 | 90.44% | 90.05% |
| 2001 | 139.41 | 136.44 | 135.91 | 132.98 | 26.01 | 25.97 | 90.24% | 90.41% |
| 2002 | 136.68 | 133.21 | 133.08 | 129.91 | 25.62 | 25.47 | 90.92% | 90.76% |
| 2003 | 126.67 | 130.06 | 123.68 | 126.91 | 25.27 | 24.98 | 90.66% | 90.91% |
| 2004 | 128.11 | 126.98 | 124.55 | 123.98 | 24.49 | 24.50 | 90.74% | 91.07% |
| 2005 | 126.99 | 127.44 | 124.47 | 124.37 | 24.14 | 24.04 | 91.36% | 91.21% |
| 2006 | 126.32 | 127.91 | 122.51 | 124.76 | 23.56 | 23.58 | 91.75% | 91.36% |
| 2007 | 128.76 | 128.38 | 126.28 | 125.16 | 22.96 | 23.12 | 91.70% | 91.51% |
| 2008 | 129.51 | 128.84 | 126.84 | 125.55 | 22.55 | 22.68 | 91.55% | 91.65% |
| 2009 | 130.62 | 129.31 | 127.35 | 125.95 | 22.24 | 22.25 | 92.05% | 91.79% |
| 2010 | 127.76 | 129.79 | 123.86 | 126.35 | 21.93 | 21.82 | 91.67% | 91.93% |
| 2011 | 130.98 | 130.26 | 127.36 | 126.74 | 21.58 | 21.56 | 92.39% | 92.06% |
| 2012 | 130.03 | 130.74 | 126.63 | 127.15 | 21.34 | 21.29 | 91.92% | 92.19% |
| 2013 | 131.04 | 131.21 | 127.27 | 127.55 | 20.84 | 21.03 | 92.26% | 92.33% |
| 2014 | 132.22 | 131.69 | 126.80 | 127.95 | 20.68 | 20.77 | 92.22% | 92.46% |
| 2015 | 132.66 | 132.17 | 129.12 | 128.35 | 20.47 | 20.52 | 92.93% | 92.58% |
| 2016 | 132.30 | 132.65 | 128.80 | 128.76 | 20.22 | 20.27 | 93.12% | 92.71% |
| 2017 | 133.57 | 133.14 | 129.86 | 129.17 | 20.07 | 20.02 | - | 92.83% |
| 2018 | 134.95 | 135.45 | 130.64 | 131.17 | 19.96 | 19.77 | - | 92.95% |
| 2019 | 137.81 | 137.81 | 133.81 | 133.21 | 19.60 | 19.53 | - | 93.07% |
| 2020 | 124.68 | 140.21 | 120.55 | 135.29 | 19.29 | 19.29 | - | 93.19% |
| 2021 | 142.77 | 142.65 | 137.22 | 137.39 | 19.06 | 19.06 | - | 93.30% |
| 2022 | - | - | - | - | 18.72 | 18.82 | - | 93.42% |
New cases come from SEER 12. Deaths come from U.S. Mortality.
All Races, Females. Rates are Age-Adjusted.
Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.
The 2020 incidence rate is displayed but not used in the fit of the trend line(s). Impact of COVID on SEER Cancer Incidence 2020 data
New cases are also referred to as incident cases in other publications. Rates of new cases are also referred to as incidence rates.
Rate of New Cases and Deaths per 100,000: The rate of new cases of female breast cancer was 129.4 per 100,000 women per year. The death rate was 19.3 per 100,000 women per year. These rates are age-adjusted and based on 2017–2021 cases and 2018–2022 deaths.
Lifetime Risk of Developing Cancer: Approximately 13.1 percent of women will be diagnosed with female breast cancer at some point during their lifetime, based on 2018–2021 data, excluding 2020 due to COVID.
Prevalence of This Cancer: In 2021, there were an estimated 3,972,256 women living with female breast cancer in the United States.
Did You Know? Video Series
How Many People Survive 5 Years Or More after Being Diagnosed with Female Breast Cancer?
Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It excludes the risk of dying from other causes. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.
5-Year
Relative Survival
91.2%
Based on data from SEER 22 (Excluding IL/MA) 2014–2020. Gray figures represent those who have died from female breast cancer. Green figures represent those who have survived 5 years or more.
Additional Information
- More about survival statistics
- Additional female breast cancer survival statistics in SEER*Explorer
Survival by Stage
Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. The earlier female breast cancer is caught, the better chance a person has of surviving five years after being diagnosed. For female breast cancer, 63.5% are diagnosed at the local stage. The 5-year relative survival for localized female breast cancer is 99.6%.
Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Female Breast Cancer
| Stage | Percent of Cases | 5-Year Relative Survival |
|---|---|---|
| Localized Confined to Primary Site | 63% | 99.6% |
| Regional Spread to Regional Lymph Nodes | 28% | 86.7% |
| Distant Cancer Has Metastasized | 6% | 31.9% |
| Unknown Unstaged | 3% | 69.7% |
Percent of Cases by Stage
Localized (63%)
Confined to Primary Site- Regional (28%)
Spread to Regional Lymph Nodes - Distant (6%)
Cancer Has Metastasized - Unknown (3%)
Unstaged
Localized (63%)
Regional (28%)
Distant (6%)
Unknown (3%)5-Year Relative Survival
SEER 22 (Excluding IL/MA) 2014–2020, All Races, Females by SEER Combined Summary Stage
Additional Information
- More about female breast cancer staging
- Additional statistics on female breast cancer by stage in SEER*Explorer
How Common Is This Cancer?
Compared to other cancers, female breast cancer is fairly common.
| Rank | Common Types of Cancer | Estimated New Cases 2024 | Estimated Deaths 2024 |
|---|---|---|---|
| 1. | Breast Cancer (Female) | 310,720 | 42,250 |
| 2. | Prostate Cancer | 299,010 | 35,250 |
| 3. | Lung and Bronchus Cancer | 234,580 | 125,070 |
| 4. | Colorectal Cancer | 152,810 | 53,010 |
| 5. | Melanoma of the Skin | 100,640 | 8,290 |
| 6. | Bladder Cancer | 83,190 | 16,840 |
| 7. | Kidney and Renal Pelvis Cancer | 81,610 | 14,390 |
| 8. | Non-Hodgkin Lymphoma | 80,620 | 20,140 |
| 9. | Uterine Cancer | 67,880 | 13,250 |
| 10. | Pancreatic Cancer | 66,440 | 51,750 |
Female breast cancer represents 15.5% of all new cancer cases in the U.S.
15.5%
In 2024, it is estimated that there will be 310,720 new cases of female breast cancer and an estimated 42,250 people will die of this disease.
Who Gets This Cancer?
Female breast cancer is most common in middle-aged and older women. Although rare, men can develop breast cancer as well. The rate of new cases of female breast cancer was 129.4 per 100,000 women per year based on 2017–2021 cases, age-adjusted.
Rate of New Cases per 100,000 Persons by Race/Ethnicity: Female Breast Cancer
Males
| All Races | Sex-specific cancer type |
|---|---|
| Hispanic | |
| Non-Hispanic American Indian/Alaska Native | |
| Non-Hispanic Asian/Pacific Islander | |
| Non-Hispanic Black | |
| Non-Hispanic White |
Females
| All Races | 129.4 |
|---|---|
| Hispanic | 101.2 |
| Non-Hispanic American Indian/Alaska Native | 113.0 |
| Non-Hispanic Asian/Pacific Islander | 110.3 |
| Non-Hispanic Black | 129.3 |
| Non-Hispanic White | 139.0 |
- All Races
- Hispanic
- Non-Hispanic American Indian/
Alaska Native - Non-Hispanic Asian /
Pacific Islander - Non-Hispanic Black
- Non-Hispanic White
SEER 22 2017–2021, Age-Adjusted
Percent of New Cases by Age Group: Female Breast Cancer
| Age Range | Percent of New Cases |
|---|---|
| <20 | 0.0% |
| 20–34 | 2.0% |
| 35–44 | 8.4% |
| 45–54 | 18.2% |
| 55–64 | 25.1% |
| 65–74 | 27.1% |
| 75–84 | 14.2% |
| >84 | 5.0% |
Female breast cancer is most frequently diagnosed among women aged 65–74.
Median Age
At Diagnosis
63
SEER 22 2017–2021, All Races, Females
Who Dies From This Cancer?
Overall, female breast cancer survival is good. However, women who are diagnosed at an advanced age may be more likely than younger women to die of the disease. Female breast cancer is the fourth leading cause of cancer death in the United States. The death rate was 19.3 per 100,000 women per year based on 2018–2022, age-adjusted.
Death Rate per 100,000 Persons by Race/Ethnicity: Female Breast Cancer
Males
| All Races | Sex-specific cancer type |
|---|---|
| Hispanic | |
| Non-Hispanic American Indian/Alaska Native | |
| Non-Hispanic Asian/Pacific Islander | |
| Non-Hispanic Black | |
| Non-Hispanic White |
Females
| All Races | 19.3 |
|---|---|
| Hispanic | 13.7 |
| Non-Hispanic American Indian/Alaska Native | 17.8 |
| Non-Hispanic Asian/Pacific Islander | 11.9 |
| Non-Hispanic Black | 26.8 |
| Non-Hispanic White | 19.4 |
- All Races
- Hispanic
- Non-Hispanic American Indian/
Alaska Native - Non-Hispanic Asian /
Pacific Islander - Non-Hispanic Black
- Non-Hispanic White
U.S. 2018–2022, Age-Adjusted
Percent of Deaths by Age Group: Female Breast Cancer
| Age Range | Percent of Deaths |
|---|---|
| <20 | 0.0% |
| 20–34 | 0.9% |
| 35–44 | 4.3% |
| 45–54 | 10.4% |
| 55–64 | 20.2% |
| 65–74 | 24.9% |
| 75–84 | 21.6% |
| >84 | 17.6% |
The percent of female breast cancer deaths is highest among women aged 65–74.
Median Age
At Death
70
U.S. 2018–2022, All Races, Females
Changes Over Time
Keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.
Using statistical models for analysis, age-adjusted rates for new female breast cancer cases have been rising on average 1.0% each year over 2012–2021. Age-adjusted death rates have been falling on average 1.2% each year over 2013–2022. 5-year relative survival trends are shown below.
New Cases, Deaths and 5-Year Relative Survival
New cases come from SEER 8. Deaths come from U.S. Mortality.
All Races, Females. Rates are Age-Adjusted.
Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.
The 2020 incidence rate is displayed but not used in the fit of the trend line(s). Impact of COVID on SEER Cancer Incidence 2020 data
SEER 8 5-Year Relative Survival Percent from 1975–2016, All Races, Females.
Modeled trend lines were calculated from the underlying rates using the Joinpoint Survival Model Software.
With SEER*Explorer, you can...
- Create custom graphs and tables
- Download data and images
- Share links to results
SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.
Explore Additional Female Breast Cancer Statistics
Cancer and the Female Breast
Figure: Breast and Adjacent Lymph Nodes
Figure: The female breast along with lymph nodes and vessels. An inset shows a close-up view of the breast with the following parts labeled: lobules, lobe, ducts, nipple, areola, and fat.
Inside a woman's breast are 15 to 20 sections, or lobes. Each lobe is made of many smaller sections called lobules. Fibrous tissue and fat fill the spaces between the lobules and ducts (thin tubes that connect the lobes and nipples). Breast cancer occurs when cells in the breast grow out of control and form a growth or tumor. Tumors may be cancerous (malignant) or not cancerous (benign).
Additional Information
- Learn more about female breast cancer
Related Stat Facts by Subtype
- Female Breast Cancer Subtypes Stat Facts
More Information
Here are some resources for learning more about female breast cancer.
- About risk factors for breast cancer
- About breast cancer screening
- About symptoms and diagnosis of breast cancer
- About treatment options for breast cancer
- About clinical trials
- About breast cancer prevention
- About cancer prevention
References
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within SEER*Explorer.
Suggested Citation
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
SEER Cancer Stat Facts: Female Breast Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/breast.html
These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse SEER*Explorer. To see statistics for a specific state, go to the State Cancer Profiles.
The statistics presented in these stat facts are based on the most recent data available, most of which can be found in SEER*Explorer. In some cases, different year spans may be used.
Estimates of new cases and deaths for 2024 are projections made by the American Cancer Society (ACS), based on earlier reported data.
Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.
